Literature DB >> 25477426

The importance of considering different healthcare settings when estimating the burden of Clostridium difficile.

Jennifer L Kuntz1, Philip M Polgreen2.   

Abstract

BACKGROUND: Traditional surveillance methods may underestimate the true burden of Clostridium difficile infection (CDI) because they fail to capture cases brought to medical attention in outpatient settings or diagnosed during non-face-to-face patient-provider interactions.
METHODS: We identified CDIs diagnosed among Kaiser Permanente Northwest patients between 1 June 2005 and 30 December 2012. We categorized infections by whether they were diagnosed during an inpatient or outpatient encounter and whether they were diagnosed during a face-to-face (eg, hospitalization, outpatient visit) or non-face-to-face encounter (eg, phone, e-mail). We constructed a baseline surveillance estimate that included CDIs identified during hospitalization, representing burden captured through traditional surveillance approaches. We then constructed 2 additional estimates: 1 that included CDIs identified during outpatient face-to-face encounters and 1 that also included CDIs identified during non-face-to-face encounters.
RESULTS: We identified 8024 CDIs. Twenty-four percent occurred during a hospitalization, while the remaining CDIs were recognized in the outpatient setting. Surveillance focused on hospitalized patients would have captured less than one-quarter of total burden. The addition of cases identified during outpatient face-to-face encounters would account for 80% of CDIs. An additional 1702 CDIs would not be captured without inclusion of non-face-to-face encounters; thus, surveillance approaches that do not include telephone or e-mail encounters would miss 21% of CDIs.
CONCLUSIONS: Surveillance approaches that do not include outpatient or nontraditional encounters miss a substantial proportion of CDIs. Failure to capture these cases leads to underestimation of disease burden and difficulty in measuring interventions to control CDI.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Clostridium difficile; incidence; surveillance

Mesh:

Year:  2014        PMID: 25477426     DOI: 10.1093/cid/ciu955

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Age and gender differences in Clostridium difficile-related hospitalization trends in Madrid (Spain) over a 12-year period.

Authors:  M D Esteban-Vasallo; S Naval Pellicer; M F Domínguez-Berjón; M Cantero Caballero; Á Asensio; G Saravia; J Astray-Mochales
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-07       Impact factor: 3.267

2.  Hospital Transfer Network Structure as a Risk Factor for Clostridium difficile Infection.

Authors:  Jacob E Simmering; Linnea A Polgreen; David R Campbell; Joseph E Cavanaugh; Philip M Polgreen
Journal:  Infect Control Hosp Epidemiol       Date:  2015-06-15       Impact factor: 3.254

3.  Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection.

Authors:  Aaron C Miller; Linnea A Polgreen; Joseph E Cavanaugh; Philip M Polgreen
Journal:  Infect Control Hosp Epidemiol       Date:  2016-02-09       Impact factor: 3.254

4.  Hospital Clostridium difficile infection (CDI) incidence as a risk factor for hospital-associated CDI.

Authors:  Aaron C Miller; Linnea A Polgreen; Joseph E Cavanaugh; Philip M Polgreen
Journal:  Am J Infect Control       Date:  2016-03-02       Impact factor: 2.918

5.  Antibiotic therapy and Clostridium difficile infection - primum non nocere - first do no harm.

Authors:  Grace S Crowther; Mark H Wilcox
Journal:  Infect Drug Resist       Date:  2015-09-15       Impact factor: 4.003

6.  The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.

Authors:  Margaret A Olsen; Yinong Young-Xu; Dustin Stwalley; Ciarán P Kelly; Dale N Gerding; Mohammed J Saeed; Cedric Mahé; Erik R Dubberke
Journal:  BMC Infect Dis       Date:  2016-04-22       Impact factor: 3.090

7.  Cost-Effectiveness Analysis of Probiotic Use to Prevent Clostridium difficile Infection in Hospitalized Adults Receiving Antibiotics.

Authors:  Nicole T Shen; Jared A Leff; Yecheskel Schneider; Carl V Crawford; Anna Maw; Brian Bosworth; Matthew S Simon
Journal:  Open Forum Infect Dis       Date:  2017-07-22       Impact factor: 3.835

8.  Probiotics in hospitalized adult patients: a systematic review of economic evaluations.

Authors:  Vincent I Lau; Bram Rochwerg; Feng Xie; Jennie Johnstone; John Basmaji; Jana Balakumaran; Alla Iansavichene; Deborah J Cook
Journal:  Can J Anaesth       Date:  2019-11-12       Impact factor: 5.063

Review 9.  The Antimicrobial Stewardship Approach to Combating Clostridium Difficile.

Authors:  Eric Wenzler; Surafel G Mulugeta; Larry H Danziger
Journal:  Antibiotics (Basel)       Date:  2015-06-17

10.  Global burden of Clostridium difficile infections: a systematic review and meta-analysis.

Authors:  Evelyn Balsells; Ting Shi; Callum Leese; Iona Lyell; John Burrows; Camilla Wiuff; Harry Campbell; Moe H Kyaw; Harish Nair
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.